Skip to main content

Advertisement

Log in

Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome

  • Correspondence
  • Published:
Familial Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

De-identified data will be made available to qualified researchers after IRB approval and establishment of data transfer agreements.

References

  1. de Andrade KC, Khincha PP, Hatton JN et al (2021) Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study. Lancet Oncol 22(12):1787–1798. https://doi.org/10.1016/S1470-2045(21)00580-5

    Article  PubMed  PubMed Central  Google Scholar 

  2. Levine AJ (2020) P53 the immune response: 40 years of exploration—a plan for the future. Int J Mol Sci 21(2):541. https://doi.org/10.3390/ijms21020541

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Fugger L, Jensen LT, Rossjohn J (2020) Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell 181(1):63–80. https://doi.org/10.1016/j.cell.2020.03.007

    Article  CAS  PubMed  Google Scholar 

  4. Ma WT, Gao F, Gu K, Chen DK (2019) The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front Immunol 10:1140. https://doi.org/10.3389/fimmu.2019.01140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Slominski B, Skrzypkowska M, Ryba-Stanislawowska M, Mysliwiec M, Trzonkowski P (2021) Associations of TP53 codon 72 polymorphism with complications and comorbidities in patients with type 1 diabetes. J Mol Med (Berl) 99(5):675–683. https://doi.org/10.1007/s00109-020-02035-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We extend our gratitude to the patients, their families, and clinicians for their contributions to the study. Kathryn Nichols and Nicole Dupree provided outstanding study support via contract HHSN261201800004 with Westat Inc.

Funding

This work was funded by the intramural research program of the Division of Cancer Epidemiology and Genetics, NCI.

Author information

Authors and Affiliations

Authors

Contributions

I.H.O. and K.C.A analyzed data and drafted the manuscript. R.B. and P.P.K. created the questionnaire and obtained data. P.P.K. and S.A.S. edited the manuscript. S.A.S. provided supervision. All authors approved the final manuscript.

Corresponding author

Correspondence to Sharon A. Savage.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflict of interest

Authors do not have any competing interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Obregón, I.H., de Andrade, K.C., Bremer, R.C. et al. Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome. Familial Cancer 22, 319–321 (2023). https://doi.org/10.1007/s10689-022-00326-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-022-00326-9

Keywords

Navigation